Perspectives on Hypercortisolism Diagnosis and Management in Community and Academic Centers

Lewis Blevins, MD; Richard Auchus, MD, PhD; David Brown, MD, PhD; Amir Hamrahian, MD; and Smita Kargutkar, MD share their insights and real-world perspectives on hypercortisolism diagnosis and management, including:

• The understanding of hypercortisolism has evolved significantly over the past decades to extend beyond classic physical manifestations (e.g., central obesity, facial plethora, buffalo hump, purple striae)

• Early identification of patients with mild autonomous cortisol secretion is important as hypercortisolism can lead to age-inappropriate and treatment-resistant metabolic syndrome

• Patient identification and management approaches for hypercortisolism can differ between academic and community settings due to differences in available resources and multidisciplinary management teams

• Educating primary care providers and community endocrinologists about the consequences of hypercortisolism can be beneficial in bridging the gap between academic and community settings

Lewis Blevins, MD Meeting Moderator University of California San Francisco   San Francisco, CA	Richard Auchus, MD, PhD University of Michigan Ann Arbor, MI	David Brown, MD, PhD Private Practice Rockville, MD
Amir Hamrahian, MD Johns Hopkins University Baltimore, MD	Smita Kargutkar, MD ACE Endocrinology Associates Red Bank, NJ

Click HERE to read the supplement.

©2022 Corcept Therapeutics Incorporated. All Rights Reserved. DSE-00997 DEC 2022